TC
HOOK

Truvestments Capital’s HOOKIPA Pharma HOOK Stock Holding History

Truvestments Capital’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$4 – 1086
2024
Q4 		$4 Hold
2
– – ﹤0.01% 1016
2024
Q3 		$9 Buy
+2
New +$11 ﹤0.01% 928
2024
Q2 		– Sell
-3
Closed -$18 – 425
2024
Q1 		$18 Buy
+3
New +$21 ﹤0.01% 719

Other funds holding HOOK

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Truvestments Capital's HOOK Position: Q1 2025 in Review

Truvestments Capital sold out of HOOKIPA Pharma (HOOK) in Q1 2025, closing a stake of 2 shares — an estimated $4 sold.

Truvestments Capital first reported a position in HOOK in Q1 2024 and held it in 3 quarters. The position peaked at $18 in Q1 2024. 32 funds tracked by Wall St. Rank hold HOOK as of Q1 2025.

  • Truvestments Capital reported no remaining HOOKIPA Pharma position as of Q1 2025 after selling out during the quarter.
  • Truvestments Capital sold 2 HOOKIPA Pharma shares in Q1 2025, an estimated $4.
  • Truvestments Capital first reported a position in HOOKIPA Pharma in Q1 2024 and held it in 3 quarters.
  • Truvestments Capital's HOOKIPA Pharma position peaked at $18 in Q1 2024.
  • 32 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2025.

Based on Truvestments Capital's 13F filing for Q1 2025, filed 14 May 2025.